Tag: member

Tel Aviv, Israel, July 21, 2025 (GLOBE NEWSWIRE) -- Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced the appointment of Mr. Eliyahu Zamir as the Company’s new Chief Executive Officer, effective as of August 1, 2025. Mr. Eliyahu Zamir will replace Mr. Viki Hakmon, who will step down from his position as the Company’s Chief Executive Officer, effective as of July 31, 2025. On July 21, 2025, Mr. Hakmon also resigned from the Board of Directors, effective immediately. Mr. Hakmon’s resignation did not result from any disagreements with the Company or the Board of Directors and he will continue to support the Company as a consultant of the Company’s subsidiary, Fort Products Limited.

The Board of Directors of Ayvens is pleased to announce the appointment of Philippe de Rovira as Chief Executive Officer (“Directeur Général”) following the recommendation of the Nomination Committee as part of its succession planning exercise. This appointment will become effective on 1st December 2025. Philippe de Rovira is due to be appointed by cooptation as member of the Board of Directors of Ayvens upon his taking responsibility as Chief Executive Officer of Ayvens.

NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Class Period”), of the important August 8, 2025 lead plaintiff deadline.

MANILA, Philippines, July 21, 2025 (GLOBE NEWSWIRE) -- A newly revised Shadow Report, released by the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), calls for a fundamental shift in the World Health Organization’s (WHO) approach to global tobacco control. The report criticizes the continued neglect of harm reduction under the WHO Framework Convention on Tobacco Control (FCTC), specifically Article 1(d), which identifies harm reduction as an essential element of tobacco control.

NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), of the important August 25, 2025 lead plaintiff deadline.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Hims & Hers (HIMS) or Sarepta (SRPT) To Contact Him Directly To Discuss Their Options